Scale inhibitors are widely used to control inorganic deposition in oil and gas production, but their laboratory evaluation is often performed under aerated conditions that may not adequately represent iron-containing brines. In this study, a modified Tube Block Test methodology was developed for dynamic scale-inhibition testing under controlled dissolved-oxygen conditions. Brines were prepared and transferred under a controlled atmosphere, and dissolved O2 concentrations ranging from 8500 to <10 μg/L were evaluated at 65 and 120 °C in tests lasting up to 6 h. A commercially available phosphonate-based inhibitor was used as an industry-qualified benchmark. The results indicated that dissolved oxygen strongly affected precipitation behavior and apparent inhibitor performance. At 65 °C under aerated conditions, the presence of iron substantially accelerated capillary blockage, whereas negligible differential-pressure variation was observed in the corresponding iron-free control. At 120 °C, rapid blockage also occurred in the iron-free control, consistent with an increased contribution from CaCO3 deposition. Reducing dissolved O2 to <10 μg/L delayed blockage in iron-containing brines and improved the apparent performance of the commercial inhibitor. Under oxygen-controlled conditions, the inhibitor at 250 mg/L maintained the differential-pressure increase below 1 psi throughout the 6 h test. These findings show that dissolved-oxygen control is essential for distinguishing iron-related interference from carbonate-scaling behavior during dynamic inhibitor qualification. The proposed methodology provides a reproducible approach for extended-duration evaluation of scale inhibitors in iron-containing brines under field-relevant operating conditions.
No takes yet. Share an insight, caveat, or question.
Barros et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: